# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
The recent decision by the DEA to reschedule cannabis to Schedule III has triggered notable volatility in the market valuations...
Tuesday's announcement that the DEA is moving towards rescheduling cannabis from Schedule I to Schedule III, has already in...
The cannabis sector saw a notable upswing on Tuesday on news of the Drug Enforcement Administration's (DEA) historic decisi...
The conversation around cannabis legalization in Pennsylvania is pivoting towards a potential state-run model, akin to the exis...
Recent insights from Viridian Capital Advisors shed light on the bewildering trends in cannabis stocks. Year-to-date (YTD) data...